SLC7A1 expression is associated with seizures, predicts poor survival in patients with malignant glioma

Science Translational Medicine

Volumn 7, Issue 289, 2015, Pages

  Robert, Stephanie M ^a   Buckingham, Susan C ^a   Campbell, Susan L ^a   Robel, Stefanie ^a   Holt, Kenneth T ^a   Ogunrinu Babarinde, Toyin ^a   Warren, Paula P ^b   White, David M ^c   Reid, Meredith A ^c   Eschbacher, Jenny M ^d   Berens, Michael E ^d   Lahti, Adrienne C ^c   Nabors, Louis B ^b   Sontheimer, Harald ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE TRANSPORTER; GLUTAMIC ACID; SLC7A11 PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG; AMINO ACID TRANSPORTER; GLUTAMIC ACID DERIVATIVE; NEUROTOXIN; SLC7A11 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; EXCITOTOXICITY; GENE FUNCTION; GENE IDENTIFICATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONCOGENE; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEIZURE; SLC7A11 GENE; SURVIVAL RATE; CLASSIFICATION; COMPLICATION; DRUG EFFECTS; EDEMA; GENOMICS; GLIOMA; METABOLISM; NERVE CELL; PATHOLOGY; SURVIVAL ANALYSIS;

AMINO ACID TRANSPORT SYSTEM Y+; EDEMA; GENOMICS; GLIOMA; GLUTAMATES; HUMANS; NEURONS; NEUROTOXINS; SEIZURES; SURVIVAL ANALYSIS;

EID: 84930145913     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aaa8103     Document Type: Article

References (61)

1. H. J. Marcus, K. L. H. Carpenter, S. J. Price, P. J. Hutchinson, In vivo assessment of high-grade glioma biochemistry using microdialysis: A study of energy-related molecules, growth factors and cytokines. J. Neurooncol 97,11-23 (2010).
2. 2+-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells. Nat. Med. 8, 971-978 (2002).
3. T. W. Lai, S. Zhang, Y. T. Wang, Excitotoxicity and stroke: Identifying novel targets for neuroprotection. Prog. Neurobiol. 115, 157-188 (2014).
4. P. Bonova, J. Burda, V. Danielisova, M. Nemethova, M. Gottlieb, Delayed post-conditioning reduces post-ischemic glutamate level and improves protein synthesis in brain. Neurochem. Int. 62, 854-860 (2013).
5. S. C. Buckingham, S. L. Campbell, B. R. Haas, V. Montana, S. Robel, T. Ogunrinu, H. Sontheimer, Glutamate release by primary brain tumors induces epileptic activity. Nat. Med. 17, 1269-1274 (2011).
6. T. I. Yuen, A. P. Morokoff, A. Bjorksten, G. D'Abaco, L. Paradiso, S. Finch, D. Wong, C. A. Reid, K. L. Powell, K. J. Drummond, M. A. Rosenthal, A. H. Kaye, T. J. O'Brien, Glutamate is associated with a higher risk of seizures in patients with gliomas. Neurology 79,883-889 (2012).
7. E. Matthew, A. L. Sherwin, S. A. Welner, K. Odusote, J. G. Stratford, Seizures following intracranial surgery: Incidence in the first post-operative week. Can. J. Neurol. Sci. 7, 285-290 (1980).
8. M. S. M. van Breemen, R. M. Rijsman, M. J. B. Taphoorn, R. Walchenbach, H. Zwinkels, C. J. Vecht, Efficacy of anti-epileptic drugs in patients with gliomas and seizures. J. Neurol. 256, 1519-1526 (2009).
9. E. M. Wallace, M. O'Reilly, M. Twomey, A review of the use of antiepileptic drugs in high-grade central nervous system tumors. Am. J. Hosp. Palliat. Care 29, 618-621 (2012).
10. J. de Groot, H. Sontheimer, Glutamate and the biology of gliomas. Glia 59, 1181-1189 (2011).
11. T. A. Ogunrinu, H. Sontheimer, Hypoxia increases the dependence of glioma cells on glutathione. J. Biol. Chem. 285, 37716-37724 (2010).
12. S. M. Robert, T. Ogunrinu-Babarinde, K. T. Holt, H. Sontheimer, Role of glutamate transporters in redox homeostasis of the brain. Neurochem. Int. 73, 181-191 (2014).
13. S. Singh, A. R. Khan, A. K. Gupta, Role of glutathione in cancer pathophysiology and therapeutic interventions. J. Exp. Ther. Oncol. 9, 303-316 (2012).
14. H. Sato, M. Tamba, T. Ishii, S. Bannai, Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J. Biol. Chem. 274, 11455-11458 (1999).
15. H. Benveniste, J. Drejer, A. Schousboe, N. H. Diemer, Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43, 1369-1374 (1984).
16. R. C. Collins, B. H. Dobkin, D. W. Choi, Selective vulnerability of the brain: New insights into the pathophysiology of stroke. Ann. Intern. Med. 110, 992-1000 (1989).
17. Y. Ben-Ari, Limbic seizure and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14, 375-403 (1985).
18. J. W. Olney, R. C. Collins, R. S. Sloviter, Excitotoxic mechanisms of epileptic brain damage. Adv. Neurol. 44, 857-877 (1986).
19. F. Berkenbosch, L. M. Refolo, V. L. Friedrich Jr., D. Casper, M. Blum, N. K. Robakis, The Alzheimer's amyloid precursor protein is produced by type I astrocytes in primary cultures of rat neuroglia. J. Neurosci. Res. 25, 431-440 (1990).
20. K. Shukla, A. G. Thomas, D. V. Ferraris, N. Hin, R. Sattler, J. Alt, C. Rojas, B. S. Slusher, T. Tsukamoto, Inhibition of transporter-mediated cystine uptake by sulfasalazine analogs. Bioorg. Med. Chem. Lett. 21, 6184-6187 (2011).
21. P. Leuraud, L. Taillandier, L. Aguirre-Cruz, J. Medioni, E. Crinière, Y. Marie, A. M. Dutrillaux, M. Kujas, A. Duprez, J.-Y. Delattre, M.-F. Poupon, M. Sanson, Correlation between genetic alterations and growth of human malignant glioma xenografted in nude mice. Br. J. Cancer 89, 2327-2332 (2003).
22. A. Pandita, K. D. Aldape, G. Zadeh, A. Guha, C. D. James, Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR. Genes Chromosomes Cancer 39, 29-36 (2004).
23. C. Giannini, J. N. Sarkaria, A. Saito, J. H. Uhm, E. Galanis, B. L. Carlson, M. A. Schroeder, C. D. James, Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme. Neuro Oncol. 7, 164-176 (2005).
24. W. H. Hoffman, L. B. Haberly, Bursting induces persistent all-or-none EPSPs by an NMDA-dependent process in piriform cortex. J. Neurosci. 9, 206-215 (1989).
25. W. H. Hoffman, L. B. Haberly, Bursting-induced epileptiform EPSPs in slices of piriform cortex are generated by deep cells. J. Neurosci. 11, 2021-2031 (1991).
26. N. C. Institute, REMBRANDT home page (2005); http://rembrandt.nci.nih.gov.
27. M. A. Reid, L. E. Stoeckel, D. M. White, K. B. Avsar, M. S. Bolding, N. S. Akella, R. C. Knowlton, J. A. den Hollander, A. C. Lahti, Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia. Biol. Psychiatry 68, 625-633 (2010).
28. 2+-permeable AMPA receptors regulate growth of human glioblastoma via Akt activation. J. Neurosci. 27, 7987-8001 (2007).
29. Y. Piao, L. Lu, J. de Groot, AMPA receptors promote perivascular glioma invasion via β1 integrin-dependent adhesion to the extracellular matrix. Neuro Oncol. 11, 260-273 (2009).
30. S. A. Lyons, W. J. Chung, A. K. Weaver, T. Ogunrinu, H. Sontheimer, Autocrine glutamate signaling promotes glioma cell invasion. Cancer Res. 67, 9463-9471 (2007).
31. W. J. Chung, S. A. Lyons, G. M. Nelson, H. Hamza, C. L. Gladson, G. Y. Gillespie, H. Sontheimer, Inhibition of cystine uptake disrupts the growth of primary brain tumors. J. Neurosci. 25, 7101-7110 (2005).
32. N. E. Savaskan, A. Heckel, E. Hahnen, T. Engelhorn, A. Doerfler, O. Ganslandt, C. Nimsky, M. Buchfelder, I. Y. Eyüpoglu, Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema. Nat. Med. 14, 629-632 (2008).
33. Z.-C. Ye, H. Sontheimer, Glioma cells release excitotoxic concentrations of glutamate. Cancer Res. 59, 4383-4391 (1999).
34. M. Kerkhof, C. J. Vecht, Seizure characteristics and prognostic factors of gliomas. Epilepsia 54 Suppl. 9, 12-17 (2013).
35. T. Takano, J. H.-C. Lin, G. Arcuino, Q. Gao, J. Yang, M. Nedergaard, Glutamate release promotes growth of malignant gliomas. Nat. Med. 7, 1010-1015 (2001).
36. S. Takeuchi, K. Wada, T. Toyooka, N. Shinomiya, H. Shimazaki, K. Nakanishi, K. Nagatani, N. Otani, H. Osada, Y. Uozumi, H. Matsuo, H. Nawashiro, Increased xCT expression correlates with tumor invasion and outcome in patients with glioblastomas. Neurosurgery 72, 33-41 (2013).
37. C. J. Vecht, M. Kerkhof, A. Duran-Pena, Seizure prognosis in brain tumors: New insights and evidence-based management. Oncologist 19, 751-759 (2014).
38. W. Wick, O. Menn, C. Meisner, J. Steinbach, M. Hermisson, M. Tatagiba, M. Weller, Pharmacotherapy of epileptic seizures in glioma patients: Who, when, why and how long? Onkologie 28, 391-396 (2005).
39. K. L. Chaichana, S. L. Parker, A. Olivi, A. Quiñones-Hinojosa, Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas. J. Neurosurg. 111, 282-292 (2009).
40. F. Stockhammer, A. von Deimling, F. K. H. van Landeghem, Decreased expression of the active subunit of the cystine/glutamate antiporter xCT is associated with loss of heterozygosity of 1p in oligodendroglial tumours WHO grade II. Histopathology 54, 241-247 (2009).
41. 1H MR spectroscopic imaging. NMR Biomed. 16, 12-18 (2003).
42. - cystine/glutamate exchanger. Neuroch. Int. 73, 132-138 (2013).
43. L. Martinian, K. Boer, J. Middeldorp, E. M. Hol, S. M. Sisodiya, W. Squier, E. Aronica, M. Thom, Expression patterns of glial fibrillary acidic protein (GFAP)-delta in epilepsy-associated lesional pathologies. Neuropathol. Appl. Neurobiol. 35, 394-405 (2009).
44. S. K. Ludwin, Reaction of oligodendrocytes and astrocytes to trauma and implantation. A combined autoradiographic and immunohistochemical study. Lab. Invest. 52, 20-30 (1985).
45. T. Eid, N. Tu, T.-S. Lee, J. C.K. Lai, Regulation of astrocyte glutamine synthetase in epilepsy. Neurochem. Int. 63, 670-681 (2013).
46. A. A. Sosunov, X. Wu, R. A. McGovern, D. G. Coughlin, C. B. Mikell, R. R. Goodman, G. M. McKhann II, The mTOR pathway is activated in glial cells in mesial temporal sclerosis. Epilepsia 53 Suppl. 1, 78-86 (2012).
47. C. Lu, J. Li, W. Sun, L. Feng, L. Li, A. Liu, J. Li, W. Mao, H. Wei, L. Gao, X. Zhang, Z. Huang, X. Meng, Y. Wang, Elevated plasma S100B concentration is associated with mesial temporal lobe epilepsy in Han Chinese: A case-control study. Neurosci. Lett. 484, 139-142 (2010).
48. M. Brenner, Role of GFAP in CNS injuries. Neurosci. Lett. 565, 7-13 (2014).
49. K. L. Kislin, W. S. McDonough, J. M. Eschbacher, B. A. Armstrong, M. E. Berens, NHERF-1: Modulator of glioblastoma cell migration and invasion. Neoplasia 11, 377-387 (2009).
50. V. A. Cuddapah, C. W. Habela, S. Watkins, L. S. Moore, T.-T.C. Barclay, H. Sontheimer, Kinase activation of ClC-3 accelerates cytoplasmic condensation during mitotic cell rounding. Am. J. Physiol. Cell Physiol. 302, C527-C538 (2012).
51. Z.-C. Ye, J. D. Rothstein, H. Sontheimer, Compromised glutamate transport in human glioma cells: Reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange. J. Neurosci. 19, 10767-10777 (1999).
52. c-) in retinal ganglion cells and regulation by nitric oxide and oxidative stress. Cell Tissue Res. 324, 189-202 (2006).
53. Ca3.1 and ClC-3. J. Neurosci. 33, 1427-1440 (2013).
54. J. A. Hartigan, P. M. Hartigan, The dip test of unimodality. Ann. Stat. 13, 70-84 (1985).
55. S. Bannai, Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J. Biol. Chem. 261, 2256-2263 (1986).
56. -C cystine/glutamate exchanger by intracellular glutathione levels in rat astrocyte primary cultures. Glia 59, 1387-1401 (2011).
57. A. M. Jensen, S. Y. Chiu, Fluorescence measurement of changes in intracellular calcium induced by excitatory amino acids in cultured cortical astrocytes. J. Neurosci. 10, 1165-1175 (1990).
58. T. Iijima, T. Mishima, K. Akagawa, Y. Iwao, Mitochondrial hyperpolarization after transient oxygen-glucose deprivation and subsequent apoptosis in cultured rat hippocampal neurons. Brain Res. 993, 140-145 (2003).
59. H in rat cerebellar Purkinje neurons in vitro. J. Physiol. 539, 469-483 (2002).
60. A. Naressi, C. Couturier, J. M. Devos, M. Janssen, C. Mangeat, R. de Beer, D. Graveron-Demilly, Java-based graphical user interface for the MRUI quantitation package. MAGMA 12, 141-152 (2001).
61. L. Vanhamme, A. van den Boogaart, S. Van Huffel, Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J. Magn. Reson. 129, 35-43 (1997).